Photokinetic Drug Delivery: Near infrared (NIR) Induced Permeation Enhancement of Bevacizumab, Ranibizumab and Aflibercept through Human Sclera
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Photokinetic Drug Delivery: Near infrared (NIR) Induced Permeation Enhancement of Bevacizumab, Ranibizumab and Aflibercept through Human Sclera
Authors
Keywords
aflibercept, bevacizumab, permeation, photokinetic, ranibizumab, sclera
Journal
PHARMACEUTICAL RESEARCH
Volume 35, Issue 6, Pages -
Publisher
Springer Nature
Online
2018-04-04
DOI
10.1007/s11095-018-2392-7
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Formulation Stabilization and Disaggregation of Bevacizumab, Ranibizumab and Aflibercept in Dilute Solutions
- (2018) Steven A. Giannos et al. PHARMACEUTICAL RESEARCH
- Transscleral passive and iontophoretic transport: theory and analysis
- (2017) S. Kevin Li et al. Expert Opinion on Drug Delivery
- Ultrasound-mediated ocular delivery of therapeutic agents: a review
- (2016) Maxime Lafond et al. Expert Opinion on Drug Delivery
- Inhibitory Effect of Topical Aflibercept on Corneal Neovascularization in Rabbits
- (2015) Yi-Ryeung Park et al. CORNEA
- Photokinetic Drug Delivery: Light-Enhanced Permeation in anIn VitroEye Model
- (2015) Bernard F. Godley et al. JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS
- Comparing different dosing regimens of bevacizumab in the treatment of neovascular macular degeneration: study protocol for a randomised controlled trial
- (2015) Alexander JE Foss et al. Trials
- A review of anti-VEGF agents for proliferative diabetic retinopathy
- (2014) P Osaadon et al. EYE
- Expertises croisées dans la dégénérescence maculaire liée à l’âge. Focus sur la physiopathologie, l’angiogenèse, les données pharmacologiques et cliniques
- (2014) M. Weber et al. JOURNAL FRANCAIS D OPHTALMOLOGIE
- Antibodies to watch in 2015
- (2014) Janice M Reichert mAbs
- The therapeutic monoclonal antibody market
- (2014) Dawn M Ecker et al. mAbs
- Treatment of Corneal Neovascularization Using Anti-VEGF Bevacizumab
- (2014) Deli Krizova et al. Journal of Ophthalmology
- Topical Ranibizumab as a Treatment of Corneal Neovascularization
- (2013) Giulio Ferrari et al. CORNEA
- Anti-VEGF Therapy (Bevacizumab) for Sulfur Mustard-Induced Corneal Neovascularization Associated with Delayed Limbal Stem Cell Deficiency in Rabbits
- (2013) Tamar Kadar et al. CURRENT EYE RESEARCH
- Adverse events and complications associated with intravitreal injection of anti-VEGF agents: a review of literature
- (2013) K Ghasemi Falavarjani et al. EYE
- Ultrasound‐enhanced drug delivery through sclera.
- (2013) Robin Shah et al. JOURNAL OF THE ACOUSTICAL SOCIETY OF AMERICA
- Human and Methodological Sources of Variability in the Measurement of Urinary 8-Oxo-7,8-dihydro-2′-deoxyguanosine
- (2012) Lars Barregard et al. ANTIOXIDANTS & REDOX SIGNALING
- The Expanding Role of Vascular Endothelial Growth Factor Inhibitors in Ophthalmology
- (2012) Michael W. Stewart MAYO CLINIC PROCEEDINGS
- Soluble Vascular Endothelial Growth Factor Decoy Receptor FP3 Exerts Potent Antiangiogenic Effects
- (2012) De-Chao Yu et al. MOLECULAR THERAPY
- Global estimates of visual impairment: 2010
- (2011) Donatella Pascolini et al. BRITISH JOURNAL OF OPHTHALMOLOGY
- Ranibizumab and Bevacizumab for Neovascular Age-Related Macular Degeneration
- (2011) NEW ENGLAND JOURNAL OF MEDICINE
- Development of Anti-VEGF Therapies for Intraocular Use: A Guide for Clinicians
- (2011) Pearse A. Keane et al. Journal of Ophthalmology
- Ocular Drug Delivery
- (2010) Ripal Gaudana et al. AAPS Journal
- Drug delivery to the posterior segment of the eye
- (2010) Thilini Rasika Thrimawithana et al. DRUG DISCOVERY TODAY
- Ultrasound-enhanced intrascleral delivery of protein
- (2010) Alex Chi Yeung Cheung et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Iontophoretic transport of charged macromolecules across human sclera
- (2010) Poonam Chopra et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- In-vitro permeation of bevacizumab through human sclera: effect of iontophoresis application
- (2010) Silvia Pescina et al. JOURNAL OF PHARMACY AND PHARMACOLOGY
- New Techniques for Drug Delivery to the Posterior Eye Segment
- (2010) Esther Eljarrat-Binstock et al. PHARMACEUTICAL RESEARCH
- Topical Bevacizumab in the Treatment of Corneal Neovascularization
- (2009) Mohammad H. Dastjerdi ARCHIVES OF OPHTHALMOLOGY
- Effect of bevacizumab on corneal neovascularization in experimental rabbit model
- (2009) Abdulgani Ahmed et al. CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY
- Short- and long-term safety profile and efficacy of topical bevacizumab (Avastin®) eye drops against corneal neovascularization
- (2009) Yanyan Koenig et al. GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY
- Inner Blood-Retinal Barrier Transporters: Role of Retinal Drug Delivery
- (2009) Ken-ichi Hosoya et al. PHARMACEUTICAL RESEARCH
- The Effect of Topical Bevacizumab on Corneal Neovascularization
- (2008) Sang Woo Kim et al. OPHTHALMOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started